Triamcinolone acetonide in ocular therapeutics

Surv Ophthalmol. 2007 Sep-Oct;52(5):503-22. doi: 10.1016/j.survophthal.2007.06.004.

Abstract

Triamcinolone acetonide has been effectively used in ocular therapeutics for over 50 years. Its use has increased dramatically in recent years for periocular and intraocular treatment of retinal vasculature disease and uveitis. This comprehensive review discusses the pharmacokinetics of triamcinolone acetonide and summarizes its uses in a number of diseases, both intraocular and extraocular. It discusses side effects and their management. Finally, it discusses the controversy over its use.

Publication types

  • Review

MeSH terms

  • Glucocorticoids / adverse effects
  • Glucocorticoids / pharmacokinetics
  • Glucocorticoids / therapeutic use*
  • Humans
  • Keratoconjunctivitis / drug therapy
  • Macular Edema / drug therapy
  • Retinal Diseases / drug therapy
  • Triamcinolone Acetonide / adverse effects
  • Triamcinolone Acetonide / pharmacokinetics
  • Triamcinolone Acetonide / therapeutic use*
  • Uveitis / drug therapy

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide